Physician
Middletown Medical PC
Middletown Medical PC was paid $49.28M by Medicaid between Jan 2018 and Dec 2024, across 308 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 39% of everything it billed.
33Billing provider infoMIDDLETOWN MEDICAL PC
MIDDLETOWN, NY 10940
MIDDLETOWN, NY 10940
33aNPI1902855828assigned 05/08/2006
33bProvider typeFamily Medicine Physician
28Total paid$49.28M
24GClaims934,777
24DCodes billed308
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in New York
Rank by total paid#2 of 2,605
Median peer was paid$10K
This provider vs. median4,880×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 59,997 | $3.00M | |
| 2019 | 72,591 | $3.51M | |
| 2020 | 81,964 | $4.94M | |
| 2021 | 133,552 | $8.72M | |
| 2022 | 172,844 | $10.28M | |
| 2023 | 250,902 | $11.25M | |
| 2024incomplete | 162,927 | $7.58M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 39% | 156,362 | 142,159 | $19.12M |
| S9083 | Global fee urgent care centers | 14% | 51,057 | 49,354 | $6.77M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.9% | 52,191 | 48,977 | $4.41M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.3% | 11,779 | 11,727 | $2.13M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.4% | 23,825 | 23,107 | $1.68M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 1.9% | 1,571 | 789 | $920K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.8% | 7,254 | 7,226 | $870K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.7% | 4,381 | 4,369 | $829K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.7% | 16,237 | 15,991 | $826K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.4% | 24,052 | 23,570 | $699K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 14,346 | 13,947 | $614K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 5,047 | 5,039 | $491K |
296 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 9,362 | $423K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 21,920 | $407K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 19,645 | $378K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 3,901 | $366K |
| 36475 | <1% | 226 | $338K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 15,962 | $317K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 2,593 | $305K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 2,926 | $289K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 2,985 | $269K |
| 99497 | <1% | 3,629 | $260K | |
| 37241 | <1% | 42 | $253K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 814 | $214K |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 1,644 | $204K |
| 87634 | <1% | 5,555 | $196K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,620 | $182K |
| 64615 | <1% | 994 | $174K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 866 | $167K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 7,831 | $160K |
| 80061 | Lipid panel | <1% | 15,525 | $136K |
| 93000 | <1% | 8,717 | $131K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 28,407 | $130K |
| 93970 | <1% | 617 | $124K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 10,790 | $123K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 17,151 | $121K |
| 93971 | <1% | 1,040 | $120K | |
| 99051 | <1% | 8,495 | $117K | |
| 97799 | <1% | 2,066 | $102K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 12,892 | $99K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 1,304 | $98K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,808 | $97K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,137 | $87K |
| 36415 | Collection of venous blood by venipuncture | <1% | 51,633 | $84K |
| A4550 | Surgical trays | <1% | 303 | $84K |
| 80053 | Comprehensive metabolic panel | <1% | 10,932 | $83K |
| 82607 | <1% | 7,983 | $83K | |
| 99441 | <1% | 1,512 | $81K | |
| 86618 | <1% | 6,452 | $80K | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 3,097 | $77K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 590 | $76K |
| 99442 | <1% | 696 | $68K | |
| 93880 | <1% | 357 | $68K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 4,035 | $68K |
| 99205 | Prolong outpt/office vis | <1% | 259 | $64K |
| 82746 | <1% | 6,271 | $64K | |
| 93298 | <1% | 1,902 | $63K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 301 | $61K |
| 92587 | <1% | 3,099 | $59K | |
| 99223 | Prolong inpt eval add15 m | <1% | 282 | $58K |
| 95816 | <1% | 130 | $58K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 3,446 | $57K |
| 95886 | <1% | 246 | $54K | |
| 99406 | <1% | 3,352 | $49K | |
| 99443 | <1% | 380 | $49K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,530 | $48K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 165 | $47K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 7,633 | $46K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,844 | $46K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 6,305 | $46K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,231 | $45K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 825 | $43K |
| 76830 | Ultrasound, transvaginal | <1% | 371 | $43K |
| 93015 | <1% | 605 | $43K | |
| 97161 | <1% | 509 | $41K | |
| 92250 | <1% | 1,155 | $41K | |
| 80050 | General health panel | <1% | 2,086 | $41K |
| 93923 | <1% | 314 | $40K | |
| 90461 | <1% | 1,609 | $36K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 151 | $36K |
| 96127 | <1% | 6,334 | $36K | |
| 82977 | <1% | 7,094 | $36K | |
| 95812 | <1% | 90 | $35K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 3,697 | $34K |
| 81002 | <1% | 16,911 | $33K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 1,262 | $32K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 105 | $32K |
| 0011A | <1% | 803 | $30K | |
| 80076 | <1% | 5,201 | $30K | |
| 83615 | <1% | 7,080 | $30K | |
| 37252 | <1% | 27 | $29K | |
| 0012A | <1% | 739 | $28K | |
| 99173 | <1% | 8,178 | $28K | |
| 92551 | <1% | 5,333 | $27K | |
| 84439 | <1% | 4,209 | $26K | |
| 84436 | <1% | 5,116 | $25K | |
| 96111 | <1% | 167 | $23K | |
| 84479 | <1% | 5,010 | $23K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,541 | $23K |
| 36011 | <1% | 38 | $22K | |
| 99498 | <1% | 355 | $22K | |
| 90674 | <1% | 817 | $21K | |
| 0001A | <1% | 525 | $21K | |
| 80305 | <1% | 2,622 | $21K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 266 | $21K |
| 93925 | <1% | 74 | $19K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 168 | $19K |
| 0002A | <1% | 453 | $18K | |
| 86160 | <1% | 1,005 | $18K | |
| 64400 | <1% | 113 | $18K | |
| 36416 | <1% | 5,572 | $17K | |
| 11721 | <1% | 423 | $17K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 917 | $17K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 129 | $17K |
| 20553 | <1% | 358 | $16K | |
| 94729 | <1% | 244 | $15K | |
| 84550 | <1% | 4,668 | $15K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,511 | $15K |
| 94726 | <1% | 244 | $15K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 37 | $14K |
| 83655 | <1% | 1,475 | $13K | |
| L3000 | Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each | <1% | 48 | $13K |
| 99385 | <1% | 88 | $13K | |
| 94060 | <1% | 268 | $13K | |
| 95819 | <1% | 27 | $12K | |
| 80074 | <1% | 490 | $12K | |
| 96112 | <1% | 81 | $11K | |
| 82044 | <1% | 2,923 | $11K | |
| 93241 | <1% | 36 | $10K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,618 | $10K |
| 86225 | <1% | 962 | $10K | |
| 0013A | <1% | 242 | $9K | |
| 86617 | <1% | 745 | $9K | |
| 84481 | <1% | 705 | $9K | |
| 83550 | <1% | 1,518 | $8K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 64 | $8K |
| 4124F | <1% | 435 | $8K | |
| 86140 | <1% | 2,091 | $8K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 13 | $7K |
| 64405 | <1% | 123 | $7K | |
| 85651 | <1% | 2,587 | $7K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 292 | $7K |
| 82728 | <1% | 759 | $7K | |
| 93229 | <1% | 12 | $7K | |
| 83540 | <1% | 1,506 | $6K | |
| 81025 | <1% | 2,021 | $6K | |
| 82962 | <1% | 2,839 | $6K | |
| 80047 | <1% | 1,220 | $6K | |
| 20610 | <1% | 86 | $6K | |
| 86317 | <1% | 625 | $5K | |
| 87428 | <1% | 326 | $5K | |
| 92134 | <1% | 150 | $5K | |
| 93299 | <1% | 38 | $5K | |
| 90688 | <1% | 1,207 | $5K | |
| 86769 | <1% | 162 | $5K | |
| 93224 | <1% | 56 | $5K | |
| 64450 | <1% | 104 | $5K | |
| 99493 | <1% | 67 | $5K | |
| 99050 | <1% | 321 | $5K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,764 | $4K |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 370 | $4K |
| 73562 | <1% | 152 | $4K | |
| 97014 | <1% | 666 | $4K | |
| 11102 | <1% | 41 | $4K | |
| 90620 | <1% | 110 | $4K | |
| 92133 | <1% | 111 | $4K | |
| 87807 | <1% | 522 | $4K | |
| 99384 | <1% | 32 | $4K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 13 | $4K |
| 90836 | <1% | 35 | $4K | |
| 71250 | <1% | 24 | $4K | |
| 73630 | <1% | 132 | $4K | |
| 94727 | <1% | 202 | $3K | |
| 84153 | <1% | 289 | $3K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 26 | $3K |
| 85018 | <1% | 1,931 | $3K | |
| 96160 | <1% | 1,429 | $3K | |
| 0003A | <1% | 82 | $3K | |
| 88342 | <1% | 100 | $3K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 51 | $3K |
| 97803 | <1% | 361 | $3K | |
| 99446 | <1% | 213 | $2K | |
| 31231 | <1% | 12 | $2K | |
| 97802 | <1% | 24 | $2K | |
| 86235 | <1% | 54 | $2K | |
| 90686 | <1% | 1,716 | $2K | |
| 90697 | <1% | 41 | $2K | |
| 95700 | <1% | 12 | $2K | |
| 91322 | <1% | 16 | $2K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 14 | $2K |
| 0071A | <1% | 63 | $2K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 12 | $2K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 15 | $2K |
| 99177 | <1% | 446 | $2K | |
| 0052A | <1% | 48 | $2K | |
| 92002 | <1% | 26 | $2K | |
| 83735 | <1% | 440 | $2K | |
| 0072A | <1% | 43 | $2K | |
| 86038 | <1% | 235 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 159 | $2K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 409 | $2K |
| 0054A | <1% | 39 | $2K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 28 | $2K |
| 76536 | <1% | 13 | $2K | |
| 83970 | <1% | 44 | $2K | |
| 99459 | <1% | 64 | $1K | |
| 99382 | <1% | 13 | $1K | |
| 91320 | <1% | 13 | $1K | |
| 0004A | <1% | 28 | $1K | |
| 82043 | <1% | 275 | $1K | |
| 72100 | <1% | 42 | $1K | |
| 90651 | <1% | 229 | $996.26 | |
| 0134A | <1% | 26 | $991.63 | |
| 99383 | <1% | 13 | $962.30 | |
| 0051A | <1% | 21 | $866.16 | |
| 86200 | <1% | 79 | $856.25 | |
| 82570 | <1% | 262 | $846.44 | |
| 82550 | <1% | 303 | $838.04 | |
| 86703 | <1% | 137 | $836.92 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 53 | $791.64 |
| 73130 | <1% | 34 | $790.89 | |
| 86431 | <1% | 194 | $789.84 | |
| 0031A | <1% | 15 | $596.60 | |
| 96161 | <1% | 196 | $563.56 | |
| 77080 | <1% | 15 | $522.53 | |
| 95012 | <1% | 24 | $503.63 | |
| 99401 | <1% | 25 | $502.11 | |
| 92557 | <1% | 12 | $499.41 | |
| 90661 | <1% | 131 | $486.81 | |
| 90480 | <1% | 29 | $475.00 | |
| 92563 | <1% | 12 | $421.77 | |
| 93244 | <1% | 20 | $419.79 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 364 | $414.99 |
| 95117 | <1% | 38 | $412.60 | |
| 90734 | <1% | 488 | $393.51 | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | <1% | 15 | $374.50 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 28 | $342.66 |
| 93228 | <1% | 17 | $318.71 | |
| 86580 | <1% | 45 | $270.67 | |
| 82947 | <1% | 122 | $267.45 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 26 | $258.00 |
| 84484 | <1% | 78 | $255.55 | |
| 86706 | <1% | 26 | $239.35 | |
| 84100 | <1% | 66 | $234.08 | |
| 97010 | <1% | 392 | $233.18 | |
| 73610 | <1% | 13 | $231.91 | |
| 88112 | <1% | 12 | $229.83 | |
| 93242 | <1% | 20 | $223.82 | |
| 83874 | <1% | 89 | $204.13 | |
| 86376 | <1% | 28 | $196.56 | |
| 82553 | <1% | 77 | $190.73 | |
| 73030 | <1% | 12 | $186.06 | |
| 88313 | <1% | 13 | $171.38 | |
| 85027 | <1% | 39 | $159.20 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 13 | $155.21 |
| 82465 | <1% | 51 | $151.13 | |
| 85610 | <1% | 48 | $137.36 | |
| 84460 | <1% | 37 | $136.50 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 15 | $130.40 |
| 86701 | <1% | 12 | $113.88 | |
| 86762 | <1% | 15 | $108.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 16 | $102.05 |
| 51798 | <1% | 14 | $101.02 | |
| 86735 | <1% | 15 | $97.95 | |
| 86765 | <1% | 15 | $96.60 | |
| 90715 | <1% | 74 | $77.05 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 15 | $63.96 |
| 84450 | <1% | 25 | $61.41 | |
| 90656 | <1% | 94 | $56.75 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 13 | $41.62 |
| 83690 | <1% | 12 | $41.40 | |
| G8709 | Uri episodes when the patient had competing diagnoses on or three days after the episode date (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis, mastoiditis, or bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis or uti, and acne) | <1% | 799 | $17.50 |
| 83986 | <1% | 12 | $14.32 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 12 | $1.44 |
| 2001F | 0% | 1,404 | $0.00 | |
| 3008F | 0% | 16,036 | $0.00 | |
| 3080F | 0% | 140 | $0.00 | |
| 3074F | 0% | 828 | $0.00 | |
| 3079F | 0% | 475 | $0.00 | |
| 1125F | 0% | 31 | $0.00 | |
| 3044F | 0% | 844 | $0.00 | |
| 2010F | 0% | 451 | $0.00 | |
| 3075F | 0% | 208 | $0.00 | |
| 90698 | 0% | 172 | $0.00 | |
| 2023F | 0% | 386 | $0.00 | |
| 1034F | 0% | 2,538 | $0.00 | |
| 1000F | 0% | 100 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 61 | $0.00 |
| 1031F | 0% | 12 | $0.00 | |
| 90744 | 0% | 16 | $0.00 | |
| 1036F | 0% | 17 | $0.00 | |
| 91301 | 0% | 66 | $0.00 | |
| 1160F | 0% | 22,276 | $0.00 | |
| 1159F | 0% | 22,302 | $0.00 | |
| 90670 | 0% | 422 | $0.00 | |
| G8511 | Screening for depression documented as positive, follow-up plan not documented, reason not given | 0% | 785 | $0.00 |
| 3077F | 0% | 237 | $0.00 | |
| 4120F | 0% | 93 | $0.00 | |
| 2014F | 0% | 322 | $0.00 | |
| 3210F | 0% | 352 | $0.00 | |
| 90633 | 0% | 41 | $0.00 | |
| 3078F | 0% | 638 | $0.00 | |
| 3046F | 0% | 115 | $0.00 | |
| 1032F | 0% | 74 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 152 | $0.00 |
| 3051F | 0% | 76 | $0.00 | |
| 90681 | 0% | 27 | $0.00 | |
| 90655 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGULATI, RAJAN (CEO)